Diagnostics (Feb 2021)

Diagnostic Strategies for Treatment Selection in Advanced Prostate Cancer

  • Ciara S. McNevin,
  • Anne-Marie Baird,
  • Ray McDermott,
  • Stephen P. Finn

DOI
https://doi.org/10.3390/diagnostics11020345
Journal volume & issue
Vol. 11, no. 2
p. 345

Abstract

Read online

Prostate Cancer (PCa) is a leading cause of morbidity and mortality among men worldwide. For most men with PCa, their disease will follow an indolent course. However, advanced PCa is associated with poor outcomes. There has been an advent of new therapeutic options with proven efficacy for advanced PCa in the last decade which has improved survival outcomes for men with this disease. Despite this, advanced PCa continues to be associated with a high rate of death. There is a lack of strong evidence guiding the timing and sequence of these novel treatment strategies. This paper focuses on a review of the strategies for diagnostic and the current evidence available for treatment selection in advanced PCa.

Keywords